WHAT DOES IT MEAN TO ME? The Digital Pathology Association 2016 Webinar Series – Session 2 Available to Members Only Thursday, May 25, 2016 | 1pm EST Learn more about the newly released FDA Guidance for Technical Performance Assessment of...

Quantification Algorithms: Value and Progress in Standardization of IHC Breast Tissue Data April 13th, 2016 12:00 PM EST Michael Grunkin, Ph.D. Chief Executive Officer Visiopharm In collaboration with Visiopharm®, Dynamyx™ software...

I was able to see a demonstration of this new release at USCAP 2016 the other day and there are many improvements over the prior version.  The application still provides a robust worklist with fast response to cases and metadata associated...

Please Join Omnyx for a Reception at USCAP 2016 Celebrating Advances in Digital Pathology Sunday, March 13th, 2016 5:00 PM – 7:00 PM Omnyx invites you to join them for refreshments, networking and insightful conversation with your peers...

The Digital Pathology Association (DPA) recently announced its suggestion that digital pathology manufacturers currently interested in marketing Whole Slide Imaging (WSI) devices for primary diagnosis in the United States submit de novo...

Last week news was released after months of speculation, that the FDA would consider the de novo classification option for digital pathology systems as a pathway for bringing to market a moderate or low risk device which has not yet been...